| Mark Edmond Quiring, MD | |
|
305 W 20th St, Mount Pleasant, TX 75455-2327 | |
| (903) 572-2222 | |
| (903) 577-0954 |
| Full Name | Mark Edmond Quiring |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 305 W 20th St, Mount Pleasant, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356343412 | NPI | - | NPPES |
| 092208001 | Medicaid | TX | |
| 8CJ005 | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | J2263 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chambers Home Health Agency Of Northeast Texas Com | Mount pleasant, TX | Home health agency |
| Titus Regional Medical Center | Mount pleasant, TX | Hospital |
| Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
| Entity Name | Mark E. Quiring, Md, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760710701 PECOS PAC ID: 9133262736 Enrollment ID: O20100204000526 |
News Archive
Custom-tailored antibodies are regarded as promising weapons against a multitude of serious illnesses. Since they can accurately recognize specific structures on the surface of viruses, bacteria or cancer cells, they are already being deployed successfully in cancer diagnostics and therapy, as well as against numerous other diseases. The stability of the sensitive antibodies is a decisive factor in every step, from production and storage to therapeutic application.
Results of the world's first efficacy trial of an HIV-prevention approach called oral pre-exposure prophylaxis, or PrEP, were released online in the New England Journal of Medicine today.
AVEO Pharmaceuticals, Inc. a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) were presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy.
French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.
The mathematical tool, quite used in Medical Physics, takes its name from the city of Montecarlo, well-known for its bingo halls and games of chance.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Edmond Quiring, MD 305 W 20th St, Mount Pleasant, TX 75455-2327 Ph: (903) 572-2222 | Mark Edmond Quiring, MD 305 W 20th St, Mount Pleasant, TX 75455-2327 Ph: (903) 572-2222 |
News Archive
Custom-tailored antibodies are regarded as promising weapons against a multitude of serious illnesses. Since they can accurately recognize specific structures on the surface of viruses, bacteria or cancer cells, they are already being deployed successfully in cancer diagnostics and therapy, as well as against numerous other diseases. The stability of the sensitive antibodies is a decisive factor in every step, from production and storage to therapeutic application.
Results of the world's first efficacy trial of an HIV-prevention approach called oral pre-exposure prophylaxis, or PrEP, were released online in the New England Journal of Medicine today.
AVEO Pharmaceuticals, Inc. a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) were presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy.
French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.
The mathematical tool, quite used in Medical Physics, takes its name from the city of Montecarlo, well-known for its bingo halls and games of chance.
› Verified 3 days ago
Paul O Meriwether, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2320 Harts Bluff Rd, Mount Pleasant, TX 75455 Phone: 903-577-9355 Fax: 903-434-7039 | |
John H. Cannon Iii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2320 Harts Bluff Rd, Mount Pleasant, TX 75455 Phone: 903-577-9355 Fax: 903-434-7039 | |
Dr. Garry Bill Taylor, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2320 Harts Bluff Rd, Suite A, Mount Pleasant, TX 75455 Phone: 903-572-1951 Fax: 903-572-2590 | |
Dr. Craig Martin Delisi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1610 S Jefferson Ave, Mount Pleasant, TX 75455 Phone: 903-572-2273 Fax: 903-572-0696 | |
Dr. Rodney Dale Burrow, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1610 S Jefferson Ave, Mount Pleasant, TX 75455 Phone: 903-572-2273 Fax: 903-572-0696 |